alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Newest studies

Every summary in our library, newest first, as a dated timeline.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 10,751–10,775 of 27,380 studies, newest first · page 431 of 1096.

January 2021 25

  1. 2021 year only

    Retinal Changes in Transgenic Mouse Models of Alzheimer's Disease

    ✓ Peer-reviewed Brain scans and imaging Current Alzheimer research

    Key finding: Accurate and early diagnosis is currently unavailable in lifespan, hampering early intervention of potential new treatments. +4 more findings

    Full summary, score breakdown and related studies → Original source

  2. 2021 year only

    Donanemab (LY3002813) Phase 1b Study in Alzheimer's Disease: Rapid and Sustained Reduction of Brain Amyloid Measured by Florbetapir F18 Imaging

    ✓ Peer-reviewed Brain scans and imaging The journal of prevention of Alzheimer's disease

    Key finding: Treatment with donanemab resulted in rapid reduction of amyloid, even after a single dose. +4 more findings

    Full summary, score breakdown and related studies → Original source

  3. 2021 year only

    Heterogeneity of Tau Deposition and Microvascular Involvement in MCI and AD

    ✓ Peer-reviewed Brain scans and imaging Current Alzheimer research

    Key finding: High tau PET signal was generally observed in the lateral temporal and parietal cortices, with uptake in the occipital cortex in one subject. +4 more findings

    Full summary, score breakdown and related studies → Original source

  4. 2021 year only

    Accelerated Epigenetic Aging in Peripheral Blood does not Predict Dementia Risk

    ✓ Peer-reviewed Genetics Current Alzheimer research

    Key finding: There was no difference in age acceleration between dementia cases and controls. +2 more findings

    Full summary, score breakdown and related studies → Original source

  5. 2021 year only

    Relevance of a Truncated PRESENILIN 2 Transcript to Alzheimer's Disease and Neurodegeneration

    ✓ Peer-reviewed Risk genes beyond APOE Journal of Alzheimer's disease : JAD

    Key finding: PS2V levels increased in AD postmortem brain but PS2V was also present at significant levels in FTD and LBD brains. +3 more findings

    Full summary, score breakdown and related studies → Original source

  6. 2021 year only

    Microglia and its Genetics in Alzheimer's Disease

    ✓ Peer-reviewed Genetics Current Alzheimer research

    Key finding: As the main innate immune cell type in the central nervous system (CNS), microglia play a very important role in regulating neuroinflammation, which occurs commonly in neurodegenerative conditions, including AD. +4 more findings

    Full summary, score breakdown and related studies → Original source

  7. 2021 year only

    Interaction Between APOE Genotype and Diabetes in Longevity

    ✓ Peer-reviewed Genetics Journal of Alzheimer's disease : JAD

    Key finding: Diabetes was associated with shorter lifespan in APOE3 carriers (n = 12,415, HR = 1.29, 95%CI = 1.17-1.42, p < 0.001) and APOE2 carriers (n = 2,390, HR = 1.37, 95%CI = 1.10-1.69, p = 0.016), while such associations were weaker and not significant in APOE4 carriers (n = 9,490, HR = 1.11, 95%CI = 0.99-1.24, p = 0.162). +4 more findings

    Full summary, score breakdown and related studies → Original source

  8. 2021 year only

    Computerized cognitive stimulation for people with dementia or with mild cognitive impairment: a bibliometric review

    ✓ Peer-reviewed Cognitive tests and assessment Dementia & neuropsychologia

    Key finding: The data show that dementia research is exponentially developing following the evolution of widespread use of computer science. +4 more findings

    Full summary, score breakdown and related studies → Original source

  9. 2021 year only

    Cognitive Performance and Cerebrospinal Fluid Markers in Preclinical Alzheimer's Disease: Results from the Gothenburg H70 Birth Cohort Studies

    ✓ Peer-reviewed Tau biomarkers Journal of Alzheimer's disease : JAD

    Key finding: Among participants with CDR 0 (n = 259), those with amyloid (A+) and/or tau pathology (T+, N+) showed similar performance on most cognitive tests compared to participants with A-T-N-. +4 more findings

    Full summary, score breakdown and related studies → Original source

  10. 2021 year only

    Sleep Characteristics and Cognitive Function in Older Adults Without Dementia: The CABLE Study

    ✓ Peer-reviewed Tau biomarkers Journal of Alzheimer's disease : JAD

    Key finding: The Pittsburgh Sleep Quality Index (PSQI) total score was significantly negatively correlated with Montreal Cognitive Assessment (MoCA) score (p = 0.0176). +4 more findings

    Full summary, score breakdown and related studies → Original source

  11. 2021 year only

    Hyperconnectivity of Self-Referential Network as a Predictive Biomarker of the Progression of Alzheimer's Disease

    ✓ Peer-reviewed Tau biomarkers Journal of Alzheimer's disease : JAD

    Key finding: Compared to cognitively normal subjects, AD-spectrum patients (i.e., EMCI, LMCI, and AD) showed a reversing trend toward an association between CSF pathological markers and the abnormal SRN occurring during the progression of AD. +2 more findings

    Full summary, score breakdown and related studies → Original source

  12. 2021 year only

    Cerebrospinal Fluid Biomarker Levels as Markers for Nursing Home Placement and Survival Time in Alzheimer's Disease

    ✓ Peer-reviewed Tau biomarkers Current Alzheimer research

    Key finding: After 20 years of follow-up, 123 patients (95%) were deceased. +4 more findings

    Full summary, score breakdown and related studies → Original source

  13. 2021 year only

    Fluid Biomarkers of Frontotemporal Lobar Degeneration

    ✓ Peer-reviewed Biomarkers Advances in experimental medicine and biology

    Key finding: In recent years, significant progress has been made in developing biomarkers of neurodegenerative diseases: amyloid-β and tau in cerebrospinal fluid (CSF) can be used to exclude Alzheimer's disease, while neurofilament light chain (NfL) is emerging as a promising, albeit nonspecific, marker of neurodegeneration in both CSF and blood.

    Full summary, score breakdown and related studies → Original source

  14. 2021 year only

    Inhibition of miR-96-5p May Reduce Aβ42/Aβ40 Ratio via Regulating ATP-binding cassette transporter A1

    ✓ Peer-reviewed Biomarkers Journal of Alzheimer's disease : JAD

    Key finding: The expression of ABCA1 was significantly downregulated in AD models at both mRNA and protein levels. +4 more findings

    Full summary, score breakdown and related studies → Original source

  15. 2021 year only

    Plasma Neurofilament Light Chain Predicts Cognitive Progression in Prodromal and Clinical Dementia with Lewy Bodies

    ✓ Peer-reviewed Biomarkers Journal of Alzheimer's disease : JAD

    Key finding: At baseline, plasma NfL levels were higher in both probable DLB and prodromal cases compared to controls. +1 more finding

    Full summary, score breakdown and related studies → Original source

  16. 2021-01-01

    Visual Impairment, Eye Diseases, and Dementia Risk: A Systematic Review and Meta-Analysis

    ✓ Peer-reviewed Risk factors Journal of Alzheimer's disease : JAD

    Key finding: As visual impairment, cataract, and diabetic retinopathy are associated with an increased likelihood of developing dementia, early diagnosis may help identify those at risk of dementia. +4 more findings

    Full summary, score breakdown and related studies → Original source

  17. 2021-01-01

    Herbal Medicines for Diabetes Management and its Secondary Complications

    ✓ Peer-reviewed Risk factors Current diabetes reviews

    Key finding: These constituents have shown a reduction in blood glucose levels. +4 more findings

    Full summary, score breakdown and related studies → Original source

  18. 2021-01-01

    Probiotic Supplementation Improves Cognitive Function and Mood with Changes in Gut Microbiota in Community-Dwelling Older Adults: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial

    ✓ Peer-reviewed Clinical trials The journals of gerontology. Series A, Biological sciences and medical sciences

    Key finding: Relative abundance of inflammation-causing gut bacteria was significantly reduced at Week 12 in the probiotics group (p < .05). +4 more findings

    Full summary, score breakdown and related studies → Original source

  19. 2021-01-01

    Aducanumab: Appropriate Use Recommendations

    ✓ Peer-reviewed Treatments The journal of prevention of Alzheimer's disease

    Key finding: Aducanumab can substantially increase the incidence of amyloid-related imaging abnormalities (ARIA) with brain effusion or hemorrhage. +4 more findings

    Full summary, score breakdown and related studies → Original source

  20. 2021-01-01

    APOE and Alzheimer's disease: advances in genetics, pathophysiology, and therapeutic approaches

    ✓ Peer-reviewed Genetics The Lancet. Neurology

    Key finding: The APOE ε4 allele remains the strongest genetic risk factor for sporadic Alzheimer's disease and the APOE ε2 allele the strongest genetic protective factor after multiple large scale genome-wide association studies and genome-wide association meta-analyses. +4 more findings

    Full summary, score breakdown and related studies → Original source

  21. 2021-01-01

    Validity of the MemTrax Memory Test Compared to the Montreal Cognitive Assessment in the Detection of Mild Cognitive Impairment and Dementia due to Alzheimer's Disease in a Chinese Cohort

    ✓ Peer-reviewed Cognitive tests and assessment Journal of Alzheimer's disease : JAD

    Key finding: MemTrax can effectively detect both clinically diagnosed MCI and AD with better accuracy as compared to the MoCA based on AUCs in a Chinese cohort. +1 more finding

    Full summary, score breakdown and related studies → Original source

  22. 2021-01-01

    A Brief Digital Cognitive Assessment for Detection of Cognitive Impairment in Cuban Older Adults

    ✓ Peer-reviewed Cognitive tests and assessment Journal of Alzheimer's disease : JAD

    Key finding: The BHA has excellent performance characteristics in detecting cognitive impairment including dementia and MCI in a Hispanic population in Cuba and outperformed the MoCA. +1 more finding

    Full summary, score breakdown and related studies → Original source

  23. 2021-01-01

    The Computerized Cognitive Composite (C3) in an Alzheimer's Disease Secondary Prevention Trial

    ✓ Peer-reviewed Cognitive tests and assessment The journal of prevention of Alzheimer's disease

    Key finding: These findings provide support for both the feasibility and validity of C3 and computerized cognitive outcomes more generally in AD secondary prevention trials. +2 more findings

    Full summary, score breakdown and related studies → Original source

  24. 2021-01-01

    The Impact of a Global Pandemic on People Living with Dementia and Their Care Partners: Analysis of 417 Lived Experience Reports

    ✓ Peer-reviewed End-of-life care Journal of Alzheimer's disease : JAD

    Key finding: Looking at the complex effects of a global pandemic through the experiences of people living with dementia and their care partners is vital to inform healthcare priorities to restore their quality of life and health and better prepare for the future. +2 more findings

    Full summary, score breakdown and related studies → Original source

  25. 2021-01-01

    Trends in Noninvasive and Invasive Mechanical Ventilation Among Medicare Beneficiaries at the End of Life

    ✓ Peer-reviewed End-of-life care JAMA internal medicine

    Key finding: Compared with 2000, the adjusted odds ratio (AOR) for the increase in NIV use was 2.63 (95% CI, 2.46-2.82; % receipt: 0.8% vs 2.0%) for 2005 and 11.84 (95% CI, 11.11-12.61; % receipt: 0.8% vs 7.1%) for 2017. +3 more findings

    Full summary, score breakdown and related studies → Original source

Browse the library by subject, with the full score breakdown →